Clinical Trials Browser

Phase 1 × Central Nervous System Neoplasms × Sirolimus × Clear all

NCT00509431 2020-07-31

Erlotinib and Sirolimus in Treating Patients With Recurrent Malignant Glioma

Phase 1 Completed

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

NCT01135563 2019-09-20

Study of Vinblastine and Sirolimus in Children With Recurrent/Refractory Solid Tumours Including CNS Tumours

Phase 1 Completed

Recurrence, Central Nervous System Neoplasms